Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Objective To systematically assess credibility and certainty of associations between
cannabis, cannabinoids, and cannabis based medicines and human health, from …
cannabis, cannabinoids, and cannabis based medicines and human health, from …
Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer
products for complementary health or recreational use. CBD has intrinsic pharmacologic …
products for complementary health or recreational use. CBD has intrinsic pharmacologic …
A cross-sectional study of cannabidiol users
Introduction: Preclinical and clinical studies suggest that cannabidiol (CBD) found in
Cannabis spp. has broad therapeutic value. CBD products can currently be purchased …
Cannabis spp. has broad therapeutic value. CBD products can currently be purchased …
Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back
O Almogi-Hazan, R Or - International journal of molecular sciences, 2020 - mdpi.com
The Cannabis plant contains numerous components, including cannabinoids and other
active molecules. The phyto-cannabinoid activity is mediated by the endocannabinoid …
active molecules. The phyto-cannabinoid activity is mediated by the endocannabinoid …
Benefits and harms of medical cannabis: a sco** review of systematic reviews
Background There has been increased interest in the role of cannabis for treating medical
conditions. The availability of different cannabis-based products can make the side effects of …
conditions. The availability of different cannabis-based products can make the side effects of …
Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews
Cannabinoids, cannabis, and cannabis-based medicines (CBM) are increasingly used to
manage pain, with limited understanding of their efficacy and safety. We assessed …
manage pain, with limited understanding of their efficacy and safety. We assessed …
Assessment of efficacy and tolerability of medicinal cannabinoids in patients with multiple sclerosis: a systematic review and meta-analysis
MC Torres-Moreno, E Papaseit, M Torrens… - JAMA network …, 2018 - jamanetwork.com
Importance Cannabinoids have antispastic and analgesic effects; however, their role in the
treatment of multiple sclerosis (MS) symptoms is not well defined. Objective To conduct a …
treatment of multiple sclerosis (MS) symptoms is not well defined. Objective To conduct a …
Cannabinoids, endocannabinoids, and synthetic cannabimimetic molecules in neuromuscular disorders
FA Iannotti - International Journal of Molecular Sciences, 2023 - mdpi.com
Neuromuscular disorders (NMDs) encompass a large heterogeneous group of hereditary
and acquired diseases primarily affecting motor neurons, peripheral nerves, and the skeletal …
and acquired diseases primarily affecting motor neurons, peripheral nerves, and the skeletal …
[HTML][HTML] The impact of phyto-and endo-cannabinoids on central nervous system diseases: A review
Background and aim Cannabis sativa L. is a medicinal plant with a long history. Phyto-
cannabinoids are a class of compounds from C. sativa L. with varieties of structures …
cannabinoids are a class of compounds from C. sativa L. with varieties of structures …
Cannabis-based medicine for neuropathic pain and spasticity—a multicenter, randomized, double-blinded, placebo-controlled trial
JS Hansen, S Gustavsen, H Roshanisefat, M Kant… - Pharmaceuticals, 2023 - mdpi.com
Patients with multiple sclerosis (MS) and spinal cord injury (SCI) commonly sustain central
neuropathic pain (NP) and spasticity. Despite a lack of consistent evidence, cannabis-based …
neuropathic pain (NP) and spasticity. Despite a lack of consistent evidence, cannabis-based …